Fresenius Kabi AG is a healthcare company that develops, manufactures and markets pharmaceuticals and medical devices for the therapy and care for critically and chronically ill patients worldwide. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Its product portfolio comprises a range of I.V. generic drugs, infusion therapies, clinical nutrition products, medical devices and transfusion technology. The company was founded in 1999 and is based in Bad Homburg, Germany with production sites in Europe, North America, Latin America, Asia Pacific and Africa. Fresenius Kabi AG operates as a subsidiary of Fresenius SE & Co KGaA.